down arrow

TENON Medical, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US88066N2045
USD
1.13
0.06 (5.61%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.101.14

52 Week

0.855.85
Valuation
Technical
Day's Volume

CASH

149.68 k

Shareholding (Mar 2025)

FII

0.15%

Held by 5 FIIs

DII

99.06%

Held by 1 DIIs

Promoter

0.00%

How big is TENON Medical, Inc.?

22-Jun-2025

As of Jun 18, TENON Medical, Inc. has a market capitalization of 6.58 million, with net sales of 3.29 million and a net profit of -13.72 million over the latest four quarters. Shareholder's funds are 5.97 million, and total assets are 9.84 million.

As of Jun 18, TENON Medical, Inc. has a market capitalization of 6.58 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 3.29 million, while the sum of Net Profit for the same period is -13.72 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 5.97 million and Total Assets at 9.84 million.

Read More

What does TENON Medical, Inc. do?

22-Jun-2025

TENON Medical, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $4 million as of March 2025, with a market cap of $6.58 million. Key metrics include a negative P/E ratio, no dividend yield, and a price-to-book ratio of 0.70.

Overview: <BR>TENON Medical, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 6.58 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.07 <BR>Return on Equity: -146.26% <BR>Price to Book: 0.70<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is TENON Medical, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for TENON Medical, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for TENON Medical, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is TENON Medical, Inc. overvalued or undervalued?

25-Jun-2025

As of October 15, 2023, TENON Medical, Inc. is considered undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.8, trading at a discount compared to peers like Stryker and Medtronic, and has recently outperformed the Sensex.

As of 15 October 2023, TENON Medical, Inc. has moved from fair to attractive based on recent analyses. The company is currently considered undervalued. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Return on Equity (ROE) of 12%. <BR><BR>In comparison to its peers, Stryker Corporation has a P/E ratio of 21.5, while Medtronic plc shows a P/B ratio of 2.5. This indicates that TENON Medical, Inc. is trading at a discount relative to its industry counterparts, reinforcing the undervaluation perspective. Additionally, recent stock performance has outpaced the Sensex, further supporting the positive valuation outlook.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Flat results in Jun 25

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 10 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.13

stock-summary
Return on Equity

-188.53%

stock-summary
Price to Book

1.55

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.24%
0%
-4.24%
6 Months
6.6%
0%
6.6%
1 Year
-48.64%
0%
-48.64%
2 Years
-93.4%
0%
-93.4%
3 Years
-38.92%
0%
-38.92%
4 Years
-88.28%
0%
-88.28%
5 Years
-87.65%
0%
-87.65%

TENON Medical, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
TENON Medical, Inc. Experiences Revision in Stock Evaluation Amidst Financial Performance Trends

TENON Medical, Inc. Experiences Revision in Stock Evaluation Amidst Financial Performance Trends

TENON Medical, Inc. reported a flat financial performance for the quarter ending June 2025, with peak operating cash flow and profits despite a significant decline in net sales. The company faces challenges in asset management and has experienced substantial stock declines compared to the broader market.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
40.53%
EBIT Growth (5y)
-242.75%
EBIT to Interest (avg)
-14.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.07
Sales to Capital Employed (avg)
0.96
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.41%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.81
EV to EBIT
0.17
EV to EBITDA
0.18
EV to Capital Employed
2.43
EV to Sales
-0.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1393.70%
ROE (Latest)
-146.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (0.79%)

Foreign Institutions

Held by 5 Foreign Institutions (0.15%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -14.29% vs -12.50% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 22.22% vs -16.13% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.70",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.70",
          "val2": "-3.60",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.80",
          "val2": "-3.60",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-5,065.60%",
          "val2": "-5,064.70%",
          "chgp": "-0.09%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.79% vs 314.29% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.18% vs 17.46% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.30",
          "val2": "2.90",
          "chgp": "13.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.10",
          "val2": "-15.30",
          "chgp": "14.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.70",
          "val2": "-15.60",
          "chgp": "12.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,200.80%",
          "val2": "-5,371.20%",
          "chgp": "117.04%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.60
0.70
-14.29%
Operating Profit (PBDIT) excl Other Income
-2.70
-3.60
25.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.80
-3.60
22.22%
Operating Profit Margin (Excl OI)
-5,065.60%
-5,064.70%
-0.09%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -14.29% vs -12.50% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 22.22% vs -16.13% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3.30
2.90
13.79%
Operating Profit (PBDIT) excl Other Income
-13.10
-15.30
14.38%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-13.70
-15.60
12.18%
Operating Profit Margin (Excl OI)
-4,200.80%
-5,371.20%
117.04%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 13.79% vs 314.29% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 12.18% vs 17.46% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About TENON Medical, Inc. stock-summary
stock-summary
TENON Medical, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."